Company Filing History:
Years Active: 2012
Title: Michael Standen: Innovator in Pharmaceutical Chemistry
Introduction
Michael Standen is a notable inventor based in Albany, Oregon. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as cysteine protease inhibitors. His work is essential in advancing therapeutic options for various medical conditions.
Latest Patents
Michael Standen holds 1 patent related to a process for the preparation of alkyl esters of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid. This invention is crucial as it provides intermediates useful in the synthesis of (S)-N-(1-cyanocyclopropyl)-5-cyclopropyl-4,4-difluoro-2-((S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethylamino)pentanamide and related compounds.
Career Highlights
Michael is currently employed at Virobay, Inc., where he continues to innovate and contribute to the field of drug development. His expertise in chemical processes and synthesis has positioned him as a valuable asset to his team and the broader scientific community.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Barry Patrick Hart and Jeff Dener. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Michael Standen's contributions to pharmaceutical chemistry exemplify the impact of innovation in the medical field. His work on cysteine protease inhibitors is paving the way for new therapeutic advancements.